Cardiac

Chest Pain – Ten Years of Research Progress and Impact

2023-01-17T11:51:50+10:00August 22nd, 2022|Blog, Cardiac|

In 2012 we demonstrated that a two hour accelerated diagnostic protocol could safely rule out heart attack in 1 in 5 patients presenting to hospital with warning signs. This work is now widely cited in clinical practice guidelines in Australia, New Zealand, Europe, North America, Asia. However, there are always further research questions remaining.

AusHSI Cardiac Month

2023-01-17T11:52:45+10:00August 19th, 2022|Blog, Cardiac|

August 2022 is Cardiac Month at AusHSI, when we highlight the current, past and future work of our Cardiac Health Services group, who are focused on developing new knowledge to drive implementation of high value cardiovascular health services.

CSANZ and ACRA 2022 Annual Scientific Meetings

2023-01-17T11:53:21+10:00August 15th, 2022|Blog, Cardiac|

The AusHSI Cardiac Health Services Group attended the CSANZ and ACRA 2022 Annual Scientific Meetings, both held in August 2022 at the Gold Coast. The programs provided learning opportunities and fellowship, and featured cardiac research abstract poster viewings and mini-oral presentations.

Research Partnership with HeartKids for CHD LIFE+

2023-01-17T11:54:48+10:00August 3rd, 2022|Blog, Cardiac|

As the CHD LIFE+ study’s key consumer partner, HeartKids will be critical to leveraging families’ involvement in the important co-design phase. Holly Williams, Queensland State Manager, HeartKids explains how family-centred advocacy will influence the design of, and planning for, local models of care across Australia.

Co-designing Sustainable Cardiac Neurodevelopmental Models of Care for Children with CHD

2023-01-17T11:55:22+10:00July 27th, 2022|Blog, Cardiac|

The next important step in the CHD LIFE journey is CHD LIFE+. Led by AusHSI, and in partnership with cardiac centres nationally, developmental follow-up experts, HeartKids and Children’s Hospital Foundation, this program of research (2020-2024) aims to develop family-centred, long-term developmental care models across Australia, including evaluation of our CHD LIFE model.

ORBITA

2023-01-17T11:55:54+10:00July 26th, 2022|Blog, Cardiac|

The Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina (ORBITA) Study investigated the efficacy of percutaneous coronary intervention (PCI) using stents for symptom relief of stable angina (chest pain) in a double blind, placebo-controlled study. The study was the first of its kind and was the PhD project of Dr Rasha Al-Lamee, an interventional cardiologist at Imperial College London.

Go to Top